In ovarian cancer, CD44+CD117+ cells were identified as a subpopulation of cells from the primary tumor, with sustained capacity to initiate tumorigenesis in xenografts, in contrast to CD44-CD117- cells [87]. This evidence concerns the gene KIT and ovarian cancer.